Strategy and planning for chemopreventive drug development: Clinical development plans II

Journal of Cellular Biochemistry - Tập 63 Số S26 - Trang 54-71 - 1996
G J Kelloff1, James A. Crowell, Ernest T. Hawk, V E Steele, Ronald A. Lubet, Charles W. Boone, Joseph M. Covey, L A Doody, Gilbert S. Omenn, Peter Greenwald, Scott M. Lippman, David Parkinson, Donya Bagheri, Gregory T. Baxter, M. Blunden, Mary K. Doeltz, Karen Eisenhauer, Karen A. Johnson, Gene Knapp, David G. Longfellow, Winfred F. Malone, S G Nayfield, John W. Harbell, Leah M. Swall, C C Sigman
1Division of Cancer Prevention and Control (DCPC), National Cancer Institute (NCI), Bethesda, MD 20892, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kelloff, 1994, J. Cell. Biochem., 20, 55, 10.1002/jcb.240560906

, and Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: , and (eds.) Cancer Chemoprevention. Boca Raton: CRC Press, 1992, pp. 41–56.

Kelloff, 1994, Cancer Epidemiol. Biomarkers Prev., 3, 85

Kelloff, 1994, Cancer Res., 54, 2015s

Kelloff, 1995, Cancer Epidemiol. Biomarkers Prev., 4, 1

Boushey, 1995, JAMA, 274, 1049, 10.1001/jama.1995.03530130055028

Chanarin, 1994, Clin. Invest. Med., 17, 244

Childers, 1995, Cancer Epidemiol. Biomarkers Prev., 4, 155

Whitehead, 1973, J. Am. Med. Assoc., 226, 1421, 10.1001/jama.1973.03230120013003

Butterworth, 1982, Am. J. Clin. Nutr., 35, 73, 10.1093/ajcn/35.1.73

Butterworth, 1992, Am. J. Obstet. Gynecol., 166, 803, 10.1016/0002-9378(92)91337-A

Attili, 1994, J. Hepatol., 20, 315, 10.1016/S0168-8278(94)80001-4

Lim, 1994, Br. Med. J., 309, 491, 10.1136/bmj.309.6953.491

Johnston, 1994, Cancer Res., 54, 5875

Goss, 1995, Clin. Cancer Res., 1, 287

Paridaens, 1993, Eur. J. Cancer, 29A, s86, 10.1016/0959-8049(93)91079-Z

Borms, 1993, Eur. J. Cancer, 29A, s84, 10.1016/0959-8049(93)91064-R

Taylor, 1994, Cancer Res., 54, 2029s

Blot, 1993, J. Natl. Cancer Inst., 85, 1483, 10.1093/jnci/85.18.1483

National Toxicology Program (NTP). Toxicology and carcinogenesis studies of turmeric oleoresin (CAS No. 8024–37-1) (major component 79%–85% curcumin, CAS No. 458–37-7) in F344/N rats and B6C3F1 mice (feed studies). NTP Technical Report Series, No. 427, 1993.

Kelloff, 1994, J. Cell. Biochem., 20, 252

Bradlow, 1991, Carcinogenesis, 12, 1571, 10.1093/carcin/12.9.1571

Kojima, 1994, Cancer Res., 54, 1446

Murrill, 1996, Carcinogenesis, 17, 1451, 10.1093/carcin/17.7.1451

Brown, 1995, Environ. Health Perspect., 103, 708

Shutt, 1972, J. Endocrinol., 52, 299, 10.1677/joe.0.0520299

Verdeal, 1980, J. Natl. Cancer Inst., 64, 285, 10.1093/jnci/64.2.285

Goodman, 1992, Cancer Res., 52, 2752s

Hong, 1990, N. Engl. J. Med., 323, 795, 10.1056/NEJM199009203231205

Collins, 1990, J. Natl. Cancer Inst., 82, 1321, 10.1093/jnci/82.16.1321